Custom service

Cyclic Peptide Modification

Modify cyclic peptides — n-methylation, d-residues, side-chain edits — while keeping the ring

Turnaround: 4–7 weeksTypical scale: 1 – 200 mg cyclic peptideChemistry options: post-cyclization edits; N-methyl scanning for stability; non-natural residue exchange

Teams come to this service when they need to modify cyclic peptides — N-methylation, D-residues, side-chain edits — while keeping the ring. We typically start from post-cyclization edits, add N-methyl scanning for stability where the application demands it, and close the loop with non-natural residue exchange so the final modified cyclic analog panel behaves consistently across lots.

Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 4–7 weeks timeline holds in practice.

Stability-optimized cyclic analogs

SAR expansion of a cyclic lead

Edits requiring full re-synthesis beyond analog scope

Cycles whose ring size is known to be geometrically uncloseable

Cyclic products are released against connectivity, not mass alone. MS/MS fragmentation confirms the ring closure, and where multiple topologies are possible the target isomer is isolated and its ratio reported. Protease-stability data are available as an add-on.

Service Highlights

  • Post-cyclization edits as the default route, with N-methyl scanning for stability held as a proven fallback
  • Non-natural residue exchange worked into the design where the application requires it
  • Cyclization strategy (head-to-tail, disulfide, lactam, thioether) chosen from a feasibility screen, not fixed by habit
  • Analytical confirmation of every intermediate before the final release
  • Cyclic/linear and topological isomers separated and reported, with the target isomer identified by MS/MS
  • Modified cyclic analog panel delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Precursor design

    Linear precursor, cyclization sites and protecting strategy are designed around the Cyclic Peptide Modification ring size.

  2. Linear assembly

    The precursor chain is assembled with Fmoc chemistry and post-cyclization edits where relevant.

  3. Cyclization

    Ring closure is executed by N-methyl scanning for stability under screened dilution and activation conditions.

  4. Isomer separation

    RP-HPLC resolves cyclic/linear and topological isomers; the target isomer is collected.

  5. Characterization

    Connectivity, purity and identity are confirmed by MS/MS and HPLC against the specification.

  6. Release

    Modified cyclic analog panel is documented and released after QC sign-off.

Specifications & timeline

Turnaround
4–7 weeks
Typical scale
1 – 200 mg cyclic peptide
Chemistry options
post-cyclization edits; N-methyl scanning for stability; non-natural residue exchange
Deliverable
Modified cyclic analog panel
QC package
HPLC purity, MS/MS connectivity proof, isomer ratio, DMSO solubility
Shipping
Ambient with desiccant; blue ice for sensitive motifs

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.